Malaria Research Today is a free monthly online journal that collates and summarizes the latest research about Malaria, including details on prevention, treatment, causes, mosquitoes.

Volume 4 (2007), Issue 3 (March)

1. Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project.
   Malar J, 6: 17. [Abstract] [Full-text]
2. Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers.
   J Infect Dis, 195(7): 942-50. [Abstract] [Full-text]
3. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals.
   J Infect Dis, 195(7): 934-41. [Abstract] [Full-text]
4. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
   J Infect Dis, 195(7): 927-33. [Abstract] [Full-text]
5. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
   Lancet, 369(9563): 757-65. [Abstract] [Full-text]
6. Prediction of outcome in adults with severe falciparum malaria: a new scoring system.
   Malar J, 6: 24. [Abstract] [Full-text]
7. A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies.
   Malar J, 6: 19. [Abstract] [Full-text]
8. Malaria parasitemia and systemic cytokine bias in pregnancy.
   Int J Gynaecol Obstet, 97(1): 15-20. [Abstract] [Full-text]
9. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
   Malar J, 6: 25. [Abstract] [Full-text]
10. Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia.
    J Infect Dis, 195(8): 1218-26. [Abstract] [Full-text]
11. Cerebral calpain in fatal falciparum malaria.
    Neuropathol Appl Neurobiol, 33(2): 179-92. [Abstract] [Full-text]
12. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
    Clin Infect Dis, 44(8): 1067-74. [Abstract] [Full-text]
13. Antimalarial activity of 1-aryl-3,3-dialkyltriazenes.
    Bioorg Med Chem, 15(8): 2856-9. [Abstract] [Full-text]
14. L-FABP is a critical host factor for successful malaria liver stage development.
    Int J Parasitol, 37(5): 483-9. [Abstract] [Full-text]
15. Electrophysiological studies of malaria parasite-infected erythrocytes: current status.
    Int J Parasitol, 37(5): 475-82. [Abstract] [Full-text]
16. Analysis of antigen-specific antibodies and their isotypes in experimental malaria.
    Cytometry A, 71(4): 242-50. [Abstract] [Full-text]
17. Retinol supplementation in murine Plasmodium berghei malaria: effects on tissue levels, parasitaemia and lipid peroxidation.
    Int J Parasitol, 37(5): 525-37. [Abstract] [Full-text]
18. Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccine.
    Infect Immun, 75(4): 1635-42. [Abstract] [Full-text]
19. Progress in the molecular biology of malaria and the immunology of nematode infections.
    Trends Parasitol, 23(4): 175-81. [Abstract] [Full-text]
20. The uncertain burden of Plasmodium falciparum epidemics in Africa.
    Trends Parasitol, 23(4): 142-8. [Abstract] [Full-text]
21. The vaccine is dead--long live the vaccine.
    Trends Parasitol, 23(4): 129-32. [Abstract] [Full-text]
22. Evolutionary paradigm of chloroquine-resistant malaria in India.
    Trends Parasitol, 23(4): 132-5. [Abstract] [Full-text]
23. Nature or nurture in mosquito resistance to malaria?
    Trends Parasitol, 23(4): 135-8. [Abstract] [Full-text]
24. Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda.
    Health Policy, 81(2): 228-41. [Abstract] [Full-text]
25. Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection.
    Malar J, 6: 32. [Abstract] [Full-text]
26. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
    Malar J, 6: 31. [Abstract] [Full-text]
27. Antiplasmodial activity of Setaria megaphylla.
    Phytother Res, 21(4): 366-8. [Abstract] [Full-text]
28. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice.
    Phytother Res, 21(4): 337-43. [Abstract] [Full-text]
29. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.
    Nat Genet, 39(4): 523-8. [Abstract] [Full-text]

© 2004-2008 Malaria Research Today. All Rights Reserved.